What do the new health care licenses mean for players, teams?
The NHL announced today that its licensing department has received a total of 6,622 applications for medical cannabis licenses, up from 5,868 applications in 2016.
The league expects to issue its next round of licenses in the coming weeks, and will work with interested organizations to select the best applicants.
For the first time, all 32 NHL teams have been granted a medical cannabis license.
The new licenses, which are valid for up to 180 days, provide a legal way for teams to grow, cultivate and sell cannabis to players, coaches, trainers and employees, according to the league.
While the league has not publicly confirmed that its teams will be allowed to use the licenses, the NHL’s policy states that “a player may only be issued a license for use within a player’s personal or team residence” and that “an employee may only use the license to grow or cultivate cannabis for personal use and not for the commercial production or sale of cannabis products or cannabis products.”
In addition, the league’s new medical cannabis policy includes a requirement that the use of medical cannabis be limited to “a single cannabis-infused product for a single use or consumption.”
This means that players will only be allowed, for example, to use their own marijuana to treat pain and/or spasms, but not for medical purposes.
The NHL has also clarified that it does not allow players to purchase or use cannabis products from other teams, but will allow players on NHL teams to use them in their home.
This means that a player on the San Jose Sharks could sell marijuana to teammates, but also sell it to other players on their own team.
The most notable change in the NHL licensing policy is that it allows the sale of marijuana to non-team employees, including those who are part of the team’s staff.
This includes coaches, coaches’ assistants, trainers, security guards and other employees.
The expansion team also now has a team doctor.
The NFL also announced it would license its own teams to sell cannabis in the future.
The rule change will allow teams to expand their medical cannabis operations, but it will not include the league-wide expansion.
According to the NHL, it expects to work with the NFL to make sure that all players, fans and employees have access to cannabis, and to continue to grow and cultivate cannabis products in accordance with the league policy.
The league is not commenting on whether it plans to license its teams to do so.
The decision to grant medical cannabis permits to players and other team members comes on the heels of a recent lawsuit filed by the National Football League against the California Athletic Commission, alleging that it had failed to protect players from medical marijuana in violation of the state’s Proposition 215.
The NFL was ordered to pay more than $50 million in damages and the NBA and the NCAA also received significant fines.
The Colorado Supreme Court denied the NCAA and NBA’s requests to reinstate their licenses to grow marijuana, citing the state legislature’s prohibition of the cultivation of cannabis.
The NCAA appealed that ruling to the U.S. Supreme Court, which in June threw out the injunction, ruling that the NCAA had failed “to prove that its medical marijuana policy violated the state constitution.”